Opinion: Pfizer shareholder meeting offers an inside look at the pharma industry
Ensuring that Americans have fair and affordable access to the life improving medicines they need should supersede outlandish profit for a few. The result would be a healthier America and…
Pfizer’s board of directors will gather in New Jersey on Thursday for the company’s annual shareholders meeting. They will celebrate the enormous success Pfizer had in 2018, having made $53 billion in revenue and over $11 billion in profits, on top of the $11 billion windfall they posted from the Trump tax cuts alone at the end of 2017. Those numbers make Pfizer one of the most profitable companies on Earth.
Despite these enormous profits, or perhaps to generate them, Pfizer on 41 of its prescription drugs in January. This includes the company’s big-selling breast cancer medication, Ibrance, a pack of 21 pills used to treat breast cancer, in 2017, up 5% from the previous year.
